Challenges and Keys to Pharma Digitalisation Success

This document is a guide that discusses the key aspects of digitalisation in the pharmaceutical industry. It outlines the pace of innovation driven by AI and digital technologies, emphasizing the responsibility of the industry to reduce treatment costs and ensure fairness in medicine pricing. The document presents three major challenges to successful digitalisation: the need for justifiable returns on investment in digital initiatives, rising regulatory costs associated with personalized medicine, and the risks of super-optimisation in supply chain processes. Additionally, it identifies three keys to successful digitalisation: focusing on business problems rather than technology, determining effective approaches to problem-solving, and ensuring data quality and consistency. The guide concludes by encouraging collaboration among pharmaceutical suppliers, integrators, and manufacturers to achieve a more efficient and equitable sector.